Jackson Financial Inc. (JXN) Stock Price & How to Invest

Jackson Financial (NYSE: JXN) is one of the largest sellers of annuities in the United States, focused on retirement-income products such as variable annuities, registered index-linked annuities (RILAs), and fixed and fixed index annuities distributed through independent advisors and broker-dealers. The company became a standalone public company in 2021 after separating from the UK's Prudential plc, and its core business is collecting premiums, managing the associated market and longevity risk (partly through hedging and reinsurance), and paying out retirement income over time.

The investment picture centers on capital return and valuation rather than smooth accounting earnings. JXN generates large amounts of statutory cash that it returns to shareholders through a growing dividend and sizable buybacks, and it has historically traded below book value with a low forward multiple. The tradeoff is that GAAP net income can swing dramatically (even to a loss) because of market risk benefit accounting, hedging results, and reinsured business, so the stock appeals to investors comfortable with insurance complexity and volatility in exchange for yield and a discounted valuation.

GAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose. Results are sensitive to equity markets, interest rates, and policyholder behavior, and a sharp downturn could pressure hedging costs and statutory capital. The reliance on variable and index-linked annuities concentrates risk in market-linked products, and heavy capital returns leave less cushion if conditions deteriorate. Regulatory and reinsurance-related developments could also affect reported capital and future payouts.

4 analysts publish price targets on JXN, averaging $134.25 against a $122.28 price as of August 2026, or +9.8%. The published targets run from $128.00 to $140.00, a narrow spread, and the ratings split 2 buy, 2 hold, 0 sell. Over the last six months there have been 5 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full JXN forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Jackson Financial Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Record annuity sales momentum. Retail annuity sales hit a record of about $19.7 billion in 2025, up roughly 10%, and Q1 2026 retail annuity sales of about $5.3 billion were up 31% year over year. The most optimistic published target, $140.00, assumes this works close to its best case.

The case against. GAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose. The most pessimistic target, $128.00, is roughly what JXN is worth if this bites instead.

Read the full bull and bear case on JXN, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Jackson Financial Inc.'s investor relations page or your broker.

• Market cap: ~$7.8B
• 2025 adjusted operating EPS: ~$22.67
• Q1 2026 adjusted operating EPS (ex notable items): ~$5.94
• Annual dividend / yield: ~$3.60 (~3.3%)
• Price / book: ~0.86x
• 2025 retail annuity sales: ~$19.7B

JXN trades below book value with a low forward earnings multiple, a pattern common for annuity insurers whose GAAP results swing with markets and hedging. Adjusted operating earnings grew in 2025 and into Q1 2026 even though GAAP net income to common shareholders was a small loss for full-year 2025. The valuation and yield largely reflect the company's cash generation and capital-return program rather than smooth reported profit.

If you want JXN exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to JXN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get JXN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (IWN, IJS, SLYV), which spreads the position across many companies. Or build it into a focused thematic portfolio, so JXN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where JXN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

JXN is a capital-return-heavy annuity insurer trading below book value, so the story hinges on whether strong annuity sales and shareholder payouts outweigh volatile GAAP earnings and market sensitivity.

Whether JXN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is JXN a buy or a sell?, and where the stock could go from here in the JXN stock forecast.

For income investors, whether JXN pays a dividend and how the payout looks is covered in does JXN pay a dividend? And to weigh JXN against a peer, read the full side-by-side comparisons: JXN vs EQH and JXN vs LNC.